Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · IEX Real-Time Price · USD
0.471
-0.014 (-2.89%)
May 17, 2024, 4:00 PM EDT - Market closed
Company Description
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine.
Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation.
The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors.
Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems, Inc.
Country | United States |
Founded | 2016 |
IPO Date | Nov 11, 2021 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 9 |
CEO | Ms. Jennifer Ernst |
Contact Details
Address: 25821 Industrial Blvd., Suite 100 Hayward, California 94545 United States | |
Phone | (888)276-6888 |
Website | tivichealth.com |
Stock Details
Ticker Symbol | TIVC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $5.00 |
CIK Code | 0001787740 |
CUSIP Number | 888705100 |
ISIN Number | US8887052095 |
Employer ID | 81-4016391 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Jennifer Ernst | Co-Founder, Chief Executive Officer and Director |
Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
Kimberly Ann Bambach | Interim Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 15, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
May 15, 2024 | 10-Q | Quarterly Report |
May 15, 2024 | 8-K | Current Report |
May 13, 2024 | 8-K | Current Report |
May 13, 2024 | 424B4 | Prospectus |
May 9, 2024 | EFFECT | Notice of Effectiveness |
May 8, 2024 | 8-K | Current Report |
May 8, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 29, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Mar 29, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |